Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Other Non-Current Liabilities for 14 consecutive years, with $44.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities fell 15.41% year-over-year to $44.0 million; the trailing twelve-month figure through Jun 2026 stood at $44.0 million (down 15.41% YoY), and the FY2025 full-year result was $49.7 million, up 53.67% from the prior year.
• Other Non-Current Liabilities fell to $44.0 million in Q2 2026 per TNDM's latest filing, from $50.4 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $52.4 million in Q3 2025 and bottomed at $17.2 million in Q2 2022.
• Historically, Other Non-Current Liabilities has averaged $33.4 million across 5 years, with a median of $32.3 million in 2024.
• The widest YoY moves for Other Non-Current Liabilities: up 19752.59% in 2022, down 38.28% in 2022.
• Over 5 years, Other Non-Current Liabilities stood at $23.9 million in 2022, then soared by 33.08% to $31.8 million in 2023, then climbed by 1.69% to $32.4 million in 2024, then surged by 53.67% to $49.7 million in 2025, then declined by 11.45% to $44.0 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $44.0 million, $50.4 million, and $49.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.